|
Apr 11
|
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
|
|
Apr 9
|
Why You Should Retain Inari Medical (NARI) Stock for Now
|
|
Apr 2
|
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
|
|
Mar 29
|
Inari Medical (NARI) Up 4% Since Last Earnings Report: Can It Continue?
|
|
Mar 25
|
AppFolio Set to Join S&P MidCap 400; Inari Medical to Join S&P SmallCap 600
|
|
Mar 20
|
Director William Hoffman Sells 40,000 Shares of Inari Medical Inc (NARI)
|
|
Mar 14
|
Inari Medical's (NARI) ClotTriever Improves Patient Outcome
|
|
Mar 12
|
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry
|
|
Jan 15
|
Is Inari Medical (NARI) a Worthy Investment?
|
|
Jan 12
|
Inari (NARI) Preliminary Q4 Revenues Ride on Procedure Demand
|
|
Jan 9
|
Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance
|
|
Dec 20
|
Inari Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 15
|
Reasons to Retain Inari Medical (NARI) in Your Portfolio Now
|
|
Dec 7
|
Why Is Steris (STE) Down 3.4% Since Last Earnings Report?
|
|
Dec 1
|
Inari Medical, Inc. (NARI) Up 17.1% Since Last Earnings Report: Can It Continue?
|
|
Nov 30
|
Inari Medical's (NARI) PEERLESS II RCT to Boost Patient Outcome
|
|
Nov 27
|
Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT)
|
|
Aug 24
|
Inari Medical to Present at Upcoming Investor Conferences
|
|
Jul 4
|
Reasons to Add Inari Medical (NARI) Stock to Your Portfolio
|